Extracellular ATP and P2X7 receptors in neurodegeneration

By Le Feuvre R.   Brough D.   Rothwell N.  

European Journal of Pharmacology, Vol. 447, Iss. 2, 2002-07 ,pp. : 261-269

Elsevier

Access to resources Recommend Favorite

5-Substituted UTP derivatives as P2Y 2 receptor agonists #

By Knoblauch B.H.A.   Muller C.E.   Jarlebark L.   Lawoko G.   Kottke T.   Wikstrom M.A.   Heilbronn E.  

European Journal of Medicinal Chemistry, Vol. 34, Iss. 10, 1999-10 ,pp. : 809-824

Elsevier

Access to resources Recommend Favorite

Protein kinase C &unknown;-dependent pathway of extracellular signal-regulated protein kinase activation by P2Y 1 and P2Y 2 purinoceptors that activate cytosolic phospholipase A 2 in endothelial cells

By Chen B.-C.   Lin L.-L.   Lin W.-W.  

European Journal of Pharmacology, Vol. 373, Iss. 1, 1999-05 ,pp. : 101-110

Elsevier

Access to resources Recommend Favorite

Extracellular ATP and Neurodegeneration

By  

Current Drug Targets-CNS & Neurological Disorders, Vol. 2, Iss. 6, 2003-12 ,pp. : 403-412

Bentham Science Publishers

Access to resources Recommend Favorite

On the suitability of adenosine 3'-phosphate 5'-phosphosulphate as a selective P2Y receptor antagonist in intact tissues

By Bultmann R.   Tuluc F.   Starke K.  

European Journal of Pharmacology, Vol. 351, Iss. 2, 1998-06 ,pp. : 209-215

Elsevier

Access to resources Recommend Favorite